Identification of SARS‐CoV‐2 Omicron variant using spike gene target failure and genotyping assays, Gauteng, South Africa, 2021

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

(2022) Wanwisa Dejnirattisai et al.   CELL

Development of new SNP genotyping assays to discriminate the Omicron variant of SARS-CoV-2

(2022) Nobuhiro Takemae et al.   JAPANESE JOURNAL OF INFECTIOUS DISEASES

Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study

(2022) Nicole Wolter et al.   LANCET

Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa

(2022) Raquel Viana et al.   NATURE

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies

(2022) Yunlong Cao et al.   NATURE

Emergence and phenotypic characterization of the global SARS-CoV-2 C.1.2 lineage

(2022) Cathrine Scheepers et al.   Nature Communications

Emergence of a SARS-CoV-2 variant of concern with mutations in spike glycoprotein

(2021) Houriiyah Tegally et al.   NATURE

The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types

(2021) Zharko Daniloski et al.   eLife

S-Gene Target Failure as a Marker of Variant B.1.1.7 Among SARS-CoV-2 Isolates in the Greater Toronto Area, December 2020 to March 2021

(2021) Kevin A. Brown et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Omicron variant (B.1.1.529) of SARS‐CoV‐2, a global urgent public health alert!

(2021) Shou‐Jiang Gao et al.   JOURNAL OF MEDICAL VIROLOGY

Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic

(2021) Salim S Abdool Karim et al.   LANCET

A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa

(2021) Eduan Wilkinson et al.   SCIENCE